Diagnosis of COVID-19 by analysis of breath with gas chromatography-ion mobility spectrometry - a feasibility study.
Diagnosis of COVID-19 by analysis of breath with gas chromatography-ion mobility spectrometry - a feasibility study.
复制标题
DOI:
10.1016/j.eclinm.2020.100609
复制
发表时间:
2020-12
影响因子:
15.1
通讯作者:
Eddleston M
中科院分区:
文献类型:
--
作者:
Ruszkiewicz DM;Sanders D;O'Brien R;Hempel F;Reed MJ;Riepe AC;Bailie K;Brodrick E;Darnley K;Ellerkmann R;Mueller O;Skarysz A;Truss M;Wortelmann T;Yordanov S;Thomas CLP;Schaaf B;Eddleston M
There is an urgent need to rapidly distinguish COVID-19 from other respiratory conditions, including influenza, at first-presentation. Point-of-care tests not requiring laboratory- support will speed diagnosis and protect health-care staff. We studied the feasibility of using breath-analysis to distinguish these conditions with near-patient gas chromatography-ion mobility spectrometry (GC-IMS). Independent observational prevalence studies at Edinburgh, UK, and Dortmund, Germany, recruited adult patients with possible COVID-19 at hospital presentation. Participants gave a single breath-sample for VOC analysis by GC-IMS. COVID-19 infection was identified by transcription polymerase chain reaction (RT- qPCR) of oral/nasal swabs together with clinical-review. Following correction for environmental contaminants, potential COVID-19 breath-biomarkers were identified by multi-variate analysis and comparison to GC-IMS databases. A COVID-19 breath-score based on the relative abundance of a panel of volatile organic compounds was proposed and tested against the cohort data. Ninety-eight patients were recruited, of whom 21/33 (63.6%) and 10/65 (15.4%) had COVID-19 in Edinburgh and Dortmund, respectively. Other diagnoses included asthma, COPD, bacterial pneumonia, and cardiac conditions. Multivariate analysis identified aldehydes (ethanal, octanal), ketones (acetone, butanone), and methanol that discriminated COVID-19 from other conditions. An unidentified-feature with significant predictive power for severity/death was isolated in Edinburgh, while heptanal was identified in Dortmund. Differentiation of patients with definite diagnosis (25 and 65) of COVID-19 from non-COVID-19 was possible with 80% and 81.5% accuracy in Edinburgh and Dortmund respectively (sensitivity/specificity 82.4%/75%; area-under-the-receiver- operator-characteristic [AUROC] 0.87 95% CI 0.67 to 1) and Dortmund (sensitivity / specificity 90%/80%; AUROC 0.91 95% CI 0.87 to 1). These two studies independently indicate that patients with COVID-19 can be rapidly distinguished from patients with other conditions at first healthcare contact. The identity of the marker compounds is consistent with COVID-19 derangement of breath-biochemistry by ketosis, gastrointestinal effects, and inflammatory processes. Development and validation of this approach may allow rapid diagnosis of COVID-19 in the coming endemic flu seasons. MR was supported by an NHS Research Scotland Career Researcher Clinician award. DMR was supported by the University of Edinburgh ref COV_29.
登录
查看更多内容
影响因子:
3.8
作者:
Gould, Oliver;Ratcliffe, Norman;de Lacy Costello, Ben
通讯作者:
de Lacy Costello, Ben
影响因子:
4.4
作者:
Schicho R;Shaykhutdinov R;Ngo J;Nazyrova A;Schneider C;Panaccione R;Kaplan GG;Vogel HJ;Storr M
通讯作者:
Storr M
影响因子:
3.7
作者:
Arevalo-Rodriguez I;Buitrago-Garcia D;Simancas-Racines D;Zambrano-Achig P;Del Campo R;Ciapponi A;Sued O;Martinez-García L;Rutjes AW;Low N;Bossuyt PM;Perez-Molina JA;Zamora J
通讯作者:
Zamora J
影响因子:
4.6
作者:
Traxler, Selina;Bischoff, Ann-Christin;Schubert, Jochen K.
通讯作者:
Schubert, Jochen K.
影响因子:
4.3
作者:
Zhou, Menglian;Sharma, Ruchi;Fan, Xudong
通讯作者:
Fan, Xudong